Search clinical trials for: sirolimus and oseltamivir

Total 271260 results

Peking Union Medical College Hospital

Unknown

Sirolimus Combined With Low-dose Warfarin for the Treatment of Refractory PNH

Paroxysmal Nocturnal Hemoglobinuria

China
University of California, Irvine

Terminated

Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus

Pemphigus

United States
Medfavour (Beijing) Medical Co., Ltd
Chinese Academy of Medical Sciences, Fuwai Hospital; Division of Biometrics...

Unknown

NOYA CoCr Biodegradable Coating Sirolimus-Eluting Coronary Stent System

Coronary Artery Diseases

China
University of Rochester

Completed

Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm | Drug/Agent Toxicity by Tissue/Organ

United States
University Heart Center Freiburg - Bad Krozingen
Cordis, Johnson&Johnson company

Unknown

Treatment of Bifurcated Coronary Lesions With Cypher™-Stent

Coronary Artery Disease

Germany
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft Recipients

Kidney Transplantation
Shehnoor Azhar

Completed

Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT (PROTECT)

COVID 19

Pakistan
Beijing Tiantan Hospital
Alain Medical (Beijing) Co., Ltd.

Recruiting

Evaluating the Safety and Efficacy of the Maurora® DES in ICAS (Maurora ICAS)

Intracranial Arteriosclerosis | Stroke (CVA) or TIA

China
Leiden University Medical Center

Completed

Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma

Myxoid Liposarcoma | Mesenchymal Chondrosarcoma | Dedifferentiated Chondrosarcoma | Conventional Chondrosarcoma

Spain, Netherlands
University Hospital, Tours
University Hospital, Angers

Recruiting

Topical Sirolimus in Cutaneous Lymphatic Malformations (TOPICAL)

Vascular Malformations | Lymphatic Malformation

France
Stanford University
Santen Inc.

Withdrawn

Intravitreal Sirolimus as Therapeutic Approach to Uveitis (SAVE-2)

Panuveitis | Uveitis | Posterior Uveitis | Intermediate Uveitis

United States
National Institute of Diabetes and Digestive and...

Completed

Evaluating the Use of Thymoglobulin, Sirolimus, and Donor Bone Marrow With Kidney Transplantation Patients

Kidney Transplantation

United States
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Withdrawn

Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Lung Cancer
Raul Moreno

Completed

Non-acute Coronary occlusIon Treated By Everolimus ELuting Stent (CIBELES)

Coronary Artery Disease | Percutaneous Coronary Intervention | Coronary Occlusion
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Firebird2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent Registry Trial (FOCUS)

Coronary Heart Disease

China
AZ-VUB
Fund for Scientific Research, Flanders, Belgium; Belgian Government

Terminated

Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts

Type 1 Diabetes | Islet Transplantation

Belgium
Shin Kong Wu Ho-Su Memorial Hospital

Terminated

A Phase II Trial of Combined Hydroxychloroquine and Sirolimus in Soft Tissue Sarcoma

Sarcoma

Taiwan
Tufts University
National Institute on Aging (NIA)

Completed

Impact of Protein and Alkali Supplementation on Skeletal Muscle in Older Adults

Muscle Loss | Age-Related Sarcopenia

United States
University of Michigan
Roche Pharma AG

Completed

Pharmacokinetics of Tamiflu® (Oseltamivir) in Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)and or Continuous Venovenous Hemodialysis (CVVHD)

Critically Ill Renal Failure Requiring CVVHD and Oseltamivir | Critically Ill Requiring ECMO and Oseltamivir

United States
Maastricht University Medical Center
Bioriginal Europe / Asia B.V.

Completed

Stearidonic Acid and Lipid Metabolism

Lipid Metabolism Disorders

Netherlands
Biotyx Medical (Shenzhen) Co., Ltd.

Recruiting

IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease (GENIUS)

Critical Limb Ischemia (CLI)

China
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Study of MeRes100 in the Treatment of Patient With Coronary Artery Disease. (MeReS100-China)

Coronary Artery Disease
Concept Medical Inc.

Active, not recruiting

Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus Global (ABILITY)

Coronary Artery Disease | Diabetes | Acute Coronary Syndrome

Switzerland, Australia, Korea, Republic of, France, Belgium, Netherlands, United Kingdom, India, Austria, Bangladesh, Brazil, Czechia, Germany, Ireland, Italy, Malaysia, Mexico, Poland, Singapore, Sweden, Taiwan
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment

Graft Versus Host Disease

United States
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Choice Of Optimal Strategy For Bifurcation Lesions With Normal Side Branch (CROSS)

Coronary Artery Disease

Korea, Republic of
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Non-inferiority Clinical Trial to Compare the Safety and Performance of MeRes100 Sirolimus-eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions (MeRethonRCT)

Coronary Artery Disease
National Taiwan University Hospital
M.A. Med Alliance S.A.

Recruiting

Selution Sirolimus-eluting Balloon for Internal Pudendal-penile Artery Disease-related Erectile Dysfunction

Peripheral Arterial Disease | Erectile Dysfunction | Arterial Stenosis

Taiwan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant Patients

Kidney Transplantation
Boehringer Ingelheim

Completed

Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 (Afatinib) Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EGFR Mutation and/or Disease Progression Following Prior Erlotinib or Gefitinib

Carcinoma, Non-Small-Cell Lung

Spain
San Giuseppe Moscati Hospital

Completed

Everolimus Stent in Myocardial Infarction (RaCES-MI)

Acute Myocardial Infarction

Italy
Heidelberg University
Baxter Healthcare Corporation; Boehringer Ingelheim; Aventis Pharmaceuticals; European...

Completed

Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients (ESCAPE)

Hypertension | Children | Chronic Renal Failure | Acquired Kidney Disease | Congenital Kidney Disease

Czech Republic, France, Germany, Hungary, Italy, Lithuania, Poland, Portugal, Serbia, Sweden, Switzerland, Turkey
Yonsei University

Completed

Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents

Stable Angina or Acute Coronary Syndrome Considered for Percutaneous Coronary Intervention With Dyslipidemia or Hypertension

Korea, Republic of
Fred Hutchinson Cancer Center

Completed

TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients

Influenza

United States
Euro CTO Club
NHS Research and Development; Biosensors International; Asahi Intecc Co., Ltd.

Completed

A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions (EuroCTO)

Coronary Occlusion | Dyspnea | Chronic Stable Angina

United Kingdom, Spain, France, Germany, Italy, Latvia
University of Pittsburgh

Terminated

Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus Toxicity (Sirolimus)

Hypertension
Fuzhou General Hospital

Unknown

Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019

COVID-19 Pneumonia

China
Deutsches Herzzentrum Muenchen

Completed

Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft Lesions (ISAR-CABG)

Arteriosclerosis of Arterial Coronary Artery Bypass Graft

Germany
M.D. Anderson Cancer Center
Aadi Bioscience

Not yet recruiting

A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions

Leiomyosarcoma | Soft-tissue Sarcomas

United States
Meril Life Sciences Pvt. Ltd.

Unknown

Clinical Study Comparing Single Long BioMimeTM Morph Coronary Stent System vs. Two Overlapping Xience Family Coronary Stent Systems in the Treatment of Patients With Long de Novo Lesions. (Morph RCT-1)

Coronary Artery Disease
University of Chicago
Baylor College of Medicine; University of Pennsylvania; Columbia University; Astellas... and other collaborators

Completed

Comparison of Sirolimus and Azathioprine in Lung Transplantation

Delayed Graft Function | Acute Graft Rejection

United States
Chang Gung Memorial Hospital

Completed

Rapamune Improves Outcomes of Severe H1N1 Pneumonia

Hypoxemia | H1N1 Pneumonia
Samsung Medical Center
Genoss Company Limited, Suwon, Korea

Recruiting

GENOSS Coronary Stent Clinical Trial

Ischemic Heart Disease

Korea, Republic of
Vascular Therapies, Inc.

Recruiting

A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery (ACCESS2)

End Stage Renal Disease | ESRD | End Stage Kidney Disease | Arteriovenous Fistula | Vascular Access Complication | Chronic Kidney Failure | Complication of Hemodialysis | Complication of Renal Dialysis

United States, United Kingdom
Robert Nickel
The Hospital for Sick Children; Ann & Robert H Lurie Children's Hospital of... and other collaborators

Recruiting

Minimizing Toxicity in HLA-identical Related Donor Transplantation for Children With Sickle Cell Disease (SUN)

Sickle Cell Disease

United States, Canada
National Cancer Institute (NCI)

Completed

Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes

Hamartoma Syndrome, Multiple | Cowden's Disease

United States
Catholic University of the Sacred Heart

Completed

SEA-SIDE: Sirolimus Versus Everolimus-eluting Stent Randomized Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis (SEA-SIDE)

Coronary Artery Disease | Coronary Stenosis

Italy
Medical University of South Carolina
American Skin Association

Active, not recruiting

Daily Topical Rapamycin for Vitiligo

Vitiligo

United States
The University of Texas Health Science Center at...
National Institute on Aging (NIA)

Completed

Topical-RAPA Use in Inflammation Reversal and Re-setting the Epigenetic Clock (Topical-RAPA)

Aging | Epigenetics | Inflammatory Mediators

United States
Biotronik, Inc.
Medstar Health Research Institute; Biotronik AG; Baim Institute for Clinical...

Completed

Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions (BIOFLOW-V)

Myocardial Ischemia | Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Ischemic Heart Disease | Atherosclerosis, Coronary

Belgium, Israel, Spain, Korea, Republic of, United States, Switzerland, Germany, Canada, Netherlands, Hungary, Denmark, New Zealand, Australia
University of Cincinnati

Completed

Study to Evaluate Safety and Efficacy of Early Calcineurin Inhibitor Withdrawal in Primary Renal Allografts

Primary Renal Allograft

United States

Search clinical trials for: sirolimus and oseltamivir

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations